Tips for Advanced & Novel Drug Delivery Systems

Signals indicative of stability failures can manifest at various stages in pharmaceutical manufacturing and quality control. Some common symptoms include:Click to read the full article.

A thorough understanding of signals indicating OOS incidents is crucial for timely intervention. Symptoms may arise from various environments—whether on the production floor or in the laboratory. Common signals include:Click…

Recognizing early signs of data integrity issues is paramount. Symptoms can manifest in various forms, often leading to disruptions in the manufacturing process or questionable quality control results. Key signals…

The first step in addressing control strategy weaknesses is the identification of symptoms or signals that suggest a deviation or failure in quality attributes during the production or testing of…

Identifying the early signals of a post-approval change failure is crucial. Symptoms can manifest through various channels, including:Click to read the full article.

Observation of symptoms or signals is the first step in identifying potential method transfer failures. Symptoms may range from out-of-specification (OOS) results to significant deviations in analytical performance. Recognizing these…

The initial indicators that may suggest a problem with missing design space for long-acting injectables can manifest in various ways:Click to read the full article.

Identifying early signals is critical for detecting issues related to missing design space during PAI readiness. Typical symptoms include:Click to read the full article.

Identifying early warning signs is crucial in addressing method transfer failures. Symptoms that may indicate a method transfer issue include:Click to read the full article.

Identifying symptoms of a missing Design Space often begins with observations and reports from production or quality control departments. Common signals include:Click to read the full article.

When an IVIVC mismatch occurs following a formulation change, several signals may alert manufacturing and quality control teams. Common symptoms include:Click to read the full article.

Recognizing symptoms or signals indicative of a control strategy weakness is the first step in initiating an investigation. In pharmaceutical manufacturing, these can manifest as:Click to read the full article.